The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …

Human metapneumovirus (hMPV), discovered in 2001, most commonly causes upper and
lower respiratory tract infections in young children, but is also a concern for elderly subjects …

Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

Broadly neutralizing antibodies reactive against most and even all variants of the same viral
species have been described for influenza and HIV-1 (ref.). However, whether a neutralizing …

Since the discovery of human metapneumovirus (hMPV) in 2001, the virus has been
identified worldwide. hMPV is a common respiratory pathogen, particularly in infants and …

It has been 10 years since human metapneumovirus (HMPV) was identified as a causative
agent of respiratory illness in humans. Since then, numerous studies have contributed to a …

Viruses that emerge pose challenges for treatment options as their uniqueness would not
know completely. Hence, many viruses are causing high morbidity and mortality for a long …

Human metapneumovirus (HMPV) is a leading cause of acute respiratory infection,
particularly in children, immunocompromised patients, and the elderly. HMPV, which is …

Though several antivirals have been developed and marketed to treat influenza virus
infections, the development of antiviral agents with clinical activity against other respiratory …

Infection is the leading cause of morbidity and mortality in immunocompromised patients
such as hematopoietic/solid organ transplant recipients and individuals with human …